Hong Kong, China

Kei Shuen Tang

This inventor holds 1 USPTO granted patent. Top assignee: Versitech, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kei Shuen Tang. Retrieved from https://idiyas.com/inventor/kei-shuen-tang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kei Shuen Tang: Innovator in Metastatic Cell Detection

Introduction

Kei Shuen Tang is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of medical technology, particularly in the detection and isolation of metastatic cells. His innovative work has the potential to enhance cancer diagnostics and treatment.

Latest Patents

Kei Shuen Tang holds a patent titled "Method for peritoneal metastatic cell detection and isolation thereof." This patent describes a method for detecting and isolating metastatic cells from samples obtained from subjects. It also includes a device comprising a microchip designed for use in this method. Additionally, the patent outlines a method for isolating metastatic cells for culture and characterization, along with a kit for implementing the method.

Career Highlights

Kei Shuen Tang is currently associated with Versitech, Inc., where he continues to develop innovative solutions in the medical field. His work is characterized by a commitment to advancing technology that can improve patient outcomes.

Collaborations

He collaborates with talented individuals such as Sze Tsai Alice Wong and Ho Cheung Anderson Shum, contributing to a dynamic research environment.

Conclusion

Kei Shuen Tang's contributions to the field of metastatic cell detection exemplify the impact of innovation in medical technology. His work not only advances scientific knowledge but also holds promise for improving cancer diagnostics and treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…